Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexis... av Ya-Wen Lin PhD, RN, Chun-Hsiang Lin MS, MD, Cheng-Li Lin MS, Che-Huei Lin PhD, BPhar, Ming-Hung Lin PhD, BPhar

Hämta fulltext